title: FDA is to assess data linking type 2 diabetes drugs with pancreatitis.
authors.forename: Deborah
authors.initials: D
authors.lastname: Cohen
mesh_terms: D016208:Databases, Factual; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D052216:Glucagon-Like Peptide 1 / Q000037:antagonists & inhibitors*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000494:pharmacology; D010190:Pancreatic Neoplasms / Q000139:chemically induced / Q000503:physiopathology; D010195:Pancreatitis / Q000139:chemically induced* / Q000503:physiopathology; D011230:Precancerous Conditions / Q000139:chemically induced / Q000503:physiopathology; D018570:Risk Assessment; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D007004:Hypoglycemic Agents; D052216:Glucagon-Like Peptide 1